Netherlands· NL-26e1fa4fa650

Ertapenem Added Pharma 1 g poeder voor concentraat voor oplossing voor infusie

A ertapenem product containing ertapenemnatrium, registered in Netherlands by Added Pharma B.V.. The same ATC class is registered in 16 of our 19 countries.

ATC J01DH03

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about ertapenemnatriumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Ertapenem is registered in 16 of 19 countries.

Countries holding a registration under ATC J01DH03 (ertapenem), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
9 of them publish a price we can compare per daily dose

Search ertapenem products by name

Ertapenem · ATC J01DH03

16 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Netherlands
Norwayprice
Polandprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ertapenem costs, country by country.

Normalised to the WHO defined daily dose (1 g), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Ertapenem · price per daily dose (1 g)

USD · FX 28 Sept 2026

CH Switzerland$74.64

Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: ERTAPENEMNATRIUM
Manufacturer: Added Pharma B.V.
Country: Netherlands (NL)
ATC code: J01DH03
ATC class: Ertapenem
Defined daily dose: 1 g, P
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
123227

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

56 interactions on record for ertapenem.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check ertapenem against other medicines How interaction checks work

Ertapenem · interactions on record

56 records

4 severe
13 moderate
38 info

Most severe, free to view

BupropionN06AX12severe
BupropionN07BA02severe
IohexolV08AB02severe
IopamidolV08AB04severe

1 more interaction with mechanism and management, from a commercially licensed source.

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ertapenem in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ertapenem products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

Austria · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
Bulgaria · Ертапенем Аптафарма
Cyprus · Ertapenem Aptapharma
Czechia · Ertapenem Aptapharma, Ertapenem Ash
Germany · Ertapenem Steriscience
Denmark · Ertapenem "aptapharma", Ertapenem Fresenius Kabi
Estonia · Ertapenem Fresenius Kabi, Ertapenem Qilu
Spain · Ertapenem, Ertapenem Aurovitas
Finland · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
France · Ertapenem Acs Dobfar, Ertapenem Arrow
United Kingdom (Northern Ireland) · Ertapenem Acs Dobfar, Ertapenem Aspire Pharma
Greece · Ertapenem Anfarm
Croatia · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
Hungary · Ertapenem Anfarm, Ertapenem Aptapharma
Iceland · Invanz
Italy · Ertapenem Acs Dobfar, Ertapenem Aurobindo
Liechtenstein · Invanz
Lithuania · Ertapenem Qilu
Latvia · Ertapenem Qilu
Malta · Ertapenem Aptapharma
Norway · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
Poland · Ertapenem Aptapharma, Ertapenem Eugia
Portugal · Ertapenem, Ertapenem Aurovitas
Romania · Ertapenem Acs Dobfar, Ertapenem Aptapharma
Sweden · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
Slovenia · Ertapenem Aptapharma, Ertapenem Fresenius Kabi
Slovakia · Ertapenem Aptapharma, Ertapenem Ash

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/1d8efdc7-34d3-48b8-bd39-488df2451d33
GET /v1/drugs/1d8efdc7-34d3-48b8-bd39-488df2451d33?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor concentraat voor oplossing voor infusie",
  "route": "Intraveneus gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h123227_smpc.pdf",
  "strength": null,
  "atc_label": "Ertapenem",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg123227",
  "excipients": [
    "NATRIUMHYDROXIDE (E 524)",
    "NATRIUMWATERSTOFCARBONAAT (E 500 (II))",
    "STIKSTOF (HEAD SPACE) (E 941)"
  ],
  "substances": [
    "ERTAPENEMNATRIUM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h123227.pdf",
  "authorised_at": "2019/09/10",
  "procedure_number": "NL/H/4383/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "123227",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about ertapenem.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console